HRPC: The stock has seen a cumulative increase of over 20% in closing prices for three consecutive days

HRPC announced that the company's stock price increased by more than 20% cumulatively over three consecutive trading days on July 16, 2025, July 17, 2025, and July 18, 2025, which constitutes an abnormal fluctuation in stock trading. After the company's self-examination and inquiries with its controlling shareholder Harbin Pharmaceutical Group Co., Ltd. and indirect controlling shareholder Harbin Pharmaceutical Group Limited, it was confirmed that there are no significant matters or important information that should have been disclosed but were not. The company's main business includes pharmaceutical wholesale, pharmaceutical retail, providing pharmaceutical logistics services, and medical services, with no significant changes occurring